Loading organizations...
Loading organizations...
Biotechnology company developing novel antibody-based cancer therapeutics.
ProfoundBio has raised $112.0M across 1 funding round.
ProfoundBio has raised $112.0M in total across 1 funding round.
ProfoundBio has raised $112.0M in total across 1 funding round.
ProfoundBio's investors include Andrew Lam, Janus Henderson Investors, LifeSci Venture Partners, Josh Jin, Logos Capital, LYFE Capital, Medicxi, Nextech Invest, Octagon Capital, OrbiMed, Piper Heartland Healthcare Capital, RA Capital Management.
ProfoundBio has raised $112.0M across 1 funding round. Most recently, it raised $112.0M Series B in February 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 13, 2024 | $112.0M Series B | Andrew Lam | Janus Henderson Investors, LifeSci Venture Partners, Josh Jin, Logos Capital, LYFE Capital, Medicxi, Nextech Invest, Octagon Capital, OrbiMed, Piper Heartland Healthcare Capital, RA Capital Management, Surveyor Capital, T. Rowe Price Associates |